Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company
8/26/2014 10:07:16 AM
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Recipharm and Isofol Medical AB, a Gothenburg-based pharmaceutical company developing novel products for unmet needs within oncology, are pleased to announce the formation of a collaboration to strengthen the development program of Isofol’s lead drug candidate Modufolin®.
Help employers find you! Check out all the jobs and post your resume.
comments powered by